Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
McKinsey
Novartis
Daiichi Sankyo
Argus Health
Farmers Insurance
Cerilliant
Chinese Patent Office
Mallinckrodt
Johnson and Johnson

Generated: February 19, 2018

DrugPatentWatch Database Preview

Iroko Pharms Llc Company Profile

« Back to Dashboard

What is the competitive landscape for IROKO PHARMS LLC, and what generic alternatives to IROKO PHARMS LLC drugs are available?

IROKO PHARMS LLC has four approved drugs.

There are thirteen US patents protecting IROKO PHARMS LLC drugs on IROKO PHARMS LLC drugs in the past three years.

There are eighty-seven patent family members on IROKO PHARMS LLC drugs in twenty-four countries.

Summary for Iroko Pharms Llc
International Patents:87
US Patents:13
Tradenames:4
Ingredients:3
NDAs:4

Drugs and US Patents for Iroko Pharms Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Iroko Pharms Llc ZORVOLEX diclofenac CAPSULE;ORAL 204592-001 Oct 18, 2013 RX Yes No 8,679,544 ➤ Sign Up Y ➤ Sign Up
Iroko Pharms Llc TIVORBEX indomethacin CAPSULE;ORAL 204768-002 Feb 24, 2014 RX Yes Yes 8,734,847 ➤ Sign Up Y ➤ Sign Up
Iroko Pharms Llc ZORVOLEX diclofenac CAPSULE;ORAL 204592-001 Oct 18, 2013 RX Yes No 9,180,095 ➤ Sign Up ➤ Sign Up
Iroko Pharms Llc VIVLODEX meloxicam CAPSULE;ORAL 207233-001 Oct 22, 2015 RX Yes No 9,808,468 ➤ Sign Up ➤ Sign Up
Iroko Pharms Llc ZORVOLEX diclofenac CAPSULE;ORAL 204592-002 Oct 18, 2013 RX Yes Yes 9,017,721 ➤ Sign Up Y ➤ Sign Up
Iroko Pharms Llc ZORVOLEX diclofenac CAPSULE;ORAL 204592-001 Oct 18, 2013 RX Yes No 8,999,387 ➤ Sign Up ➤ Sign Up
Iroko Pharms Llc VIVLODEX meloxicam CAPSULE;ORAL 207233-001 Oct 22, 2015 RX Yes No 9,649,318 ➤ Sign Up Y ➤ Sign Up
Iroko Pharms Llc TIVORBEX indomethacin CAPSULE;ORAL 204768-001 Feb 24, 2014 RX Yes No 9,089,471 ➤ Sign Up ➤ Sign Up
Iroko Pharms Llc VIVLODEX meloxicam CAPSULE;ORAL 207233-002 Oct 22, 2015 RX Yes Yes 9,526,734 ➤ Sign Up Y ➤ Sign Up
Iroko Pharms Llc INDOCIN indomethacin CAPSULE;ORAL 016059-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for IROKO PHARMS LLC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Capsules 5 mg and 10 mg ➤ Subscribe 1/9/2017
➤ Subscribe Capsules 18 mg and 35 mg ➤ Subscribe 6/6/2014

Non-Orange Book US Patents for Iroko Pharms Llc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,735,450 Formulation of diclofenac ➤ Sign Up
9,849,111 Formulation of indomethacin ➤ Sign Up
9,095,496 Formulation of indomethacin ➤ Sign Up
9,522,135 Formulation of indomethacin ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Iroko Pharms Llc Drugs

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Harvard Business School
McKinsey
Fuji
Chubb
Daiichi Sankyo
Chinese Patent Office
Cerilliant
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot